- Email: [email protected]
Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory
Abstracts / Drug and Alcohol Dependence 171 (2017) e2–e226
Results: Three out of four completed the 12-week study, 75% were males. Among the completers, we found a more frequent use of heroin and other illicit opioids in the BP-NLX group compared to the XR-NTX group (p = .003). There was no significant difference between the groups on use of other illicit drugs including nonprescribed benzodiazepines, or on self-reported quality of life, drug craving and mental health problems. Conclusions: The results indicate that opioid blocking treatment with XR-NTX reduce illicit opioid use to a greater extent that BP-NLX, but not the use of other illicit drugs. XR-NTX may be an alternative treatment for opioid addiction and should be considered for subjects who want to terminate treatment with opioid agonists. Financial support: Grant support from The Research Council of Norway (grant # 204725-3). Financial support from Akershus University Hospital, Oslo and Norwegian Centre for Addiction Research, University of Oslo. http://dx.doi.org/10.1016/j.drugalcdep.2016.08.548 Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory L. Techer 2,∗ , Jean-Marc Alexandre 1 , David Mété 2 , Marc Auriacombe 1 , M. Fatseas 1 1 Addiction Psychiatry (CNRS USR 3413), Universite Bordeaux, Bordeaux, France 2 Addiction Treatment Center, CHU Ile de la Réunion, Saint Denis, France
Aims: To describe addictive behaviors and psychiatric comorbidities of incarcerated women in Reunion Island, France (overseas territory). Methods: From January to October 2015, women incarcerated at the penitentiary of Reunion Island were proposed an interview with the modified Addiction Severity Index (ASI) and the Mini International Neuropsychiatric Interview (MINI). Results: 32 women were included (response rate 73%) Average age was 35.5 y.o. (SD = 12.7 y.). Half of our sample was awaiting trial (n = 16). Average duration of incarceration was 19 months (SD = 49 months). Sentences ranged from 1 month to 30 years. Sixty percent of subjects (n = 19) reported current use of tobacco. Other substances used in the past 30 days were prescribed benzodiazepines (34% n = 11) and prescribed opioids (n = 1). Fifteen subjects (47%) met criteria for current tobacco dependence, 4 (13%) for alcohol, 4 (13%) for sedatives and 1 (3%) for cannabis. A third of subjects (34% n = 11) had received some treatment for addiction in the past. According to the mASI (interviewer severity ratings ≥4), half of the sample (50% n = 16) exhibited a current need for tobacco treatment, 25% (n = 8) for alcohol, and 16% for other substances. Nearly a third (31% n = 10) of women reported substance use during pregnancy. Also, 20 women (63%) were in need of psychological treatment. 41% (n = 13) had current mood disorder (75% lifetime), and half (50% n = 23) had current anxiety disorder (50% lifetime). Twenty-four women (75%) had received psychological treatment at any time during incarceration. Conclusions: Despite the efforts of prison care services, a large proportion of incarcerated women still remain in need for help for addiction and psychological comorbidities. An improvement in the detection of addictions and psychiatric comorbidities and treatment offer is needed. Financial support: Supported by internal funds.
e201
The baltimore reproductive health initiative: Bringing family planning to women in treatment Mishka Terplan 1,∗ , Jennifer Kirschner 2 , Sadiya Muqueeth 2 , Rebecca Dineen 2 1 Behavioral Health System Baltimore, Baltimore, MD, United States 2 Baltimore City Health Department, Baltimore, MD, United States
Aims: Women in substance use disorder (SUD) treatment have unique issues related to reproductive health. In addition to an increased risk for acquiring sexually transmitted infections, they have higher lifetime parity than comparison populations, report more unintended pregnancies, and have more abortions. These differences are due in part to a decreased prevalence in the use of contraception, particularly long acting reversible contraception which may be due to decreased access to preventative health services including family planning. To address the unique needs of women in treatment and reduce barriers to care, the Behavioral Health System Baltimore in collaboration with Baltimore City Health Department initiated the Baltimore Reproductive Health Initiative. This initiative involves integrating three domains into SUD treatment: screening, education, and on-site service delivery. (1) Screening: All clients are asked, “Would you like to be pregnant in the next year?” (One Key Question) at treatment intake. (2) Education: A curriculum specific to the population was developed and delivered over 6 weeks by nursing student volunteers. (3) Service delivery: Utilizing Title X as a funding and organizational framework, clinics were set up at each of the treatment sites to provide a full range of reproductive services including all contraceptive methods. Conclusions: To date the Baltimore Reproductive Initiative is integrated into three treatment sites. Over 200 women have been screened for reproductive health needs and 90 have accessed services of whom 80% needed contraception. Almost 90% of those needing contraception received a method, the most popular being the implant. This pilot program confirms the unmet reproductive health care needs of women in treatment and demonstrates the feasibility of integrating screening and onsite service delivery. Financial support: The Abell Foundation. http://dx.doi.org/10.1016/j.drugalcdep.2016.08.550 Alexithymia in alcohol-dependent patients is mediated by stress, anxiety and loss of self-control over drinking Fred Arne Thorberg 1,6,2,∗ , Ross M. Young 2 , Michael Lyvers 4 , Jason Connor 5 , Reidar Tyssen 6 , Edythe London 3 , Gerald Feeney 7 1 Natnl Cntr Dual Diagnosis, Innlandet Hosp Trust, Ottestad, Norway 2 Qld Univ Technol, Brisbane, QLD, Australia 3 Univ Calif Los Angeles, Los Angeles, CA, United States 4 Bond Univ, Gold Coast, QLD, Australia 5 Univ Qld, Brisbane, QLD, Australia 6 Behav Sciences in Medicine, Univ Oslo, Oslo, Norway 7 Princess Alex Hosp, Brisbane, QLD, Australia
http://dx.doi.org/10.1016/j.drugalcdep.2016.08.549 Aims: Up to 67% of alcohol-dependent patients in treatment have alexithymia, a personality trait associated with emotion regu-
Results: Three out of four completed the 12-week study, 75% were males. Among the completers, we found a more frequent use of heroin and other illicit opioids in the BP-NLX group compared to the XR-NTX group (p = .003). There was no significant difference between the groups on use of other illicit drugs including nonprescribed benzodiazepines, or on self-reported quality of life, drug craving and mental health problems. Conclusions: The results indicate that opioid blocking treatment with XR-NTX reduce illicit opioid use to a greater extent that BP-NLX, but not the use of other illicit drugs. XR-NTX may be an alternative treatment for opioid addiction and should be considered for subjects who want to terminate treatment with opioid agonists. Financial support: Grant support from The Research Council of Norway (grant # 204725-3). Financial support from Akershus University Hospital, Oslo and Norwegian Centre for Addiction Research, University of Oslo. http://dx.doi.org/10.1016/j.drugalcdep.2016.08.548 Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas territory L. Techer 2,∗ , Jean-Marc Alexandre 1 , David Mété 2 , Marc Auriacombe 1 , M. Fatseas 1 1 Addiction Psychiatry (CNRS USR 3413), Universite Bordeaux, Bordeaux, France 2 Addiction Treatment Center, CHU Ile de la Réunion, Saint Denis, France
Aims: To describe addictive behaviors and psychiatric comorbidities of incarcerated women in Reunion Island, France (overseas territory). Methods: From January to October 2015, women incarcerated at the penitentiary of Reunion Island were proposed an interview with the modified Addiction Severity Index (ASI) and the Mini International Neuropsychiatric Interview (MINI). Results: 32 women were included (response rate 73%) Average age was 35.5 y.o. (SD = 12.7 y.). Half of our sample was awaiting trial (n = 16). Average duration of incarceration was 19 months (SD = 49 months). Sentences ranged from 1 month to 30 years. Sixty percent of subjects (n = 19) reported current use of tobacco. Other substances used in the past 30 days were prescribed benzodiazepines (34% n = 11) and prescribed opioids (n = 1). Fifteen subjects (47%) met criteria for current tobacco dependence, 4 (13%) for alcohol, 4 (13%) for sedatives and 1 (3%) for cannabis. A third of subjects (34% n = 11) had received some treatment for addiction in the past. According to the mASI (interviewer severity ratings ≥4), half of the sample (50% n = 16) exhibited a current need for tobacco treatment, 25% (n = 8) for alcohol, and 16% for other substances. Nearly a third (31% n = 10) of women reported substance use during pregnancy. Also, 20 women (63%) were in need of psychological treatment. 41% (n = 13) had current mood disorder (75% lifetime), and half (50% n = 23) had current anxiety disorder (50% lifetime). Twenty-four women (75%) had received psychological treatment at any time during incarceration. Conclusions: Despite the efforts of prison care services, a large proportion of incarcerated women still remain in need for help for addiction and psychological comorbidities. An improvement in the detection of addictions and psychiatric comorbidities and treatment offer is needed. Financial support: Supported by internal funds.
e201
The baltimore reproductive health initiative: Bringing family planning to women in treatment Mishka Terplan 1,∗ , Jennifer Kirschner 2 , Sadiya Muqueeth 2 , Rebecca Dineen 2 1 Behavioral Health System Baltimore, Baltimore, MD, United States 2 Baltimore City Health Department, Baltimore, MD, United States
Aims: Women in substance use disorder (SUD) treatment have unique issues related to reproductive health. In addition to an increased risk for acquiring sexually transmitted infections, they have higher lifetime parity than comparison populations, report more unintended pregnancies, and have more abortions. These differences are due in part to a decreased prevalence in the use of contraception, particularly long acting reversible contraception which may be due to decreased access to preventative health services including family planning. To address the unique needs of women in treatment and reduce barriers to care, the Behavioral Health System Baltimore in collaboration with Baltimore City Health Department initiated the Baltimore Reproductive Health Initiative. This initiative involves integrating three domains into SUD treatment: screening, education, and on-site service delivery. (1) Screening: All clients are asked, “Would you like to be pregnant in the next year?” (One Key Question) at treatment intake. (2) Education: A curriculum specific to the population was developed and delivered over 6 weeks by nursing student volunteers. (3) Service delivery: Utilizing Title X as a funding and organizational framework, clinics were set up at each of the treatment sites to provide a full range of reproductive services including all contraceptive methods. Conclusions: To date the Baltimore Reproductive Initiative is integrated into three treatment sites. Over 200 women have been screened for reproductive health needs and 90 have accessed services of whom 80% needed contraception. Almost 90% of those needing contraception received a method, the most popular being the implant. This pilot program confirms the unmet reproductive health care needs of women in treatment and demonstrates the feasibility of integrating screening and onsite service delivery. Financial support: The Abell Foundation. http://dx.doi.org/10.1016/j.drugalcdep.2016.08.550 Alexithymia in alcohol-dependent patients is mediated by stress, anxiety and loss of self-control over drinking Fred Arne Thorberg 1,6,2,∗ , Ross M. Young 2 , Michael Lyvers 4 , Jason Connor 5 , Reidar Tyssen 6 , Edythe London 3 , Gerald Feeney 7 1 Natnl Cntr Dual Diagnosis, Innlandet Hosp Trust, Ottestad, Norway 2 Qld Univ Technol, Brisbane, QLD, Australia 3 Univ Calif Los Angeles, Los Angeles, CA, United States 4 Bond Univ, Gold Coast, QLD, Australia 5 Univ Qld, Brisbane, QLD, Australia 6 Behav Sciences in Medicine, Univ Oslo, Oslo, Norway 7 Princess Alex Hosp, Brisbane, QLD, Australia
http://dx.doi.org/10.1016/j.drugalcdep.2016.08.549 Aims: Up to 67% of alcohol-dependent patients in treatment have alexithymia, a personality trait associated with emotion regu-